Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 13795

1.

Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer.

Zhang B, Ye H, Ren X, Zheng S, Zhou Q, Chen C, Lin Q, Li G, Wei L, Fu Z, Zhang Y, Hu C, Li Z, Chen R.

Cancer Lett. 2019 Jun 11. pii: S0304-3835(19)30366-0. doi: 10.1016/j.canlet.2019.06.005. [Epub ahead of print]

PMID:
31199988
2.

The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis.

Fang L, Du WW, Awan FM, Dong J, Yang BB.

Cancer Lett. 2019 Jun 11. pii: S0304-3835(19)30331-3. doi: 10.1016/j.canlet.2019.05.036. [Epub ahead of print]

PMID:
31199987
3.

Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer.

Ho DW, Tsui YM, Sze KM, Chan LK, Cheung TT, Lee E, Sham PC, Tsui SK, Lee TK, Ng IO.

Cancer Lett. 2019 Jun 10. pii: S0304-3835(19)30363-5. doi: 10.1016/j.canlet.2019.06.002. [Epub ahead of print]

PMID:
31195060
4.

Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines.

Lynn GM, Laga R, Jewell CM.

Cancer Lett. 2019 Jun 8. pii: S0304-3835(19)30349-0. doi: 10.1016/j.canlet.2019.114427. [Epub ahead of print]

PMID:
31185250
5.

New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.

Ezzaidi N, Zhang X, Coker OO, Yu J.

Cancer Lett. 2019 Jun 8. pii: S0304-3835(19)30347-7. doi: 10.1016/j.canlet.2019.114425. [Epub ahead of print]

PMID:
31185249
6.

MDM2-NFAT1 Dual Inhibitor, MA242: Effective against Hepatocellular Carcinoma, Independent of p53.

Wang W, Cheng J, Qin JJ, Hu B, Li X, Nijampatnam B, Velu SE, Fan J, Yang XR, Zhang R.

Cancer Lett. 2019 Jun 7:114429. doi: 10.1016/j.canlet.2019.114429. [Epub ahead of print]

PMID:
31181320
7.

CFIm25 and alternative polyadenylation: Conflicting roles in cancer.

Jafari Najaf Abadi MH, Shafabakhsh R, Asemi Z, Mirzaei HR, Sahebnasagh R, Mirzei H, Hamblin MR.

Cancer Lett. 2019 Jun 7;459:112-121. doi: 10.1016/j.canlet.2019.114430. [Epub ahead of print]

PMID:
31181319
8.

DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.

Yao H, Tang H, Zhang Y, Zhang QF, Liu XY, Liu YT, Gu WT, Zheng YZ, Shang HB, Wang Y, Huang JY, Wei YX, Zhang X, Zhang J, Wu ZB.

Cancer Lett. 2019 Jun 6;459:135-144. doi: 10.1016/j.canlet.2019.05.043. [Epub ahead of print]

PMID:
31176743
9.

Modulation of regulatory T cells by natural products in cancer.

Bahrami A, Fereidouni M, Pirro M, Bianconi V, Sahebkar A.

Cancer Lett. 2019 Jun 6;459:72-85. doi: 10.1016/j.canlet.2019.06.001. [Epub ahead of print]

PMID:
31176742
10.

Corrigendum to "The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)" [Cancer Lett. 392 (1) (2017) 9-16].

Gazi M, Moharram SA, Marhäll A, Kazi JU.

Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30301-5. doi: 10.1016/j.canlet.2019.05.012. [Epub ahead of print] No abstract available.

PMID:
31174904
11.

Corrigendum to "Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer" [Cancer Lett. 431 (2018) 105-114].

Cheng X, Feng H, Wu H, Jin Z, Shen X, Kuang J, Huo Z, Chen X, Gao H, Ye F, Ji X, Jing X, Zhang Y, Zhang T, Qiu W, Zhao R.

Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30315-5. doi: 10.1016/j.canlet.2019.05.020. [Epub ahead of print] No abstract available.

PMID:
31174903
12.

Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner.

Tan L, Chen S, Wei G, Li Y, Liao J, Jin H, Zou Y, Huang M, Peng Z, Guo Y, Peng S, Xu L, Kuang M.

Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30342-8. doi: 10.1016/j.canlet.2019.05.041. [Epub ahead of print]

PMID:
31173855
13.

PI3Kα Inhibitors Sensitize Esophageal Squamous Cell Carcinoma to Radiation by Abrogating Survival Signals in Tumor Cells and Tumor Microenvironment.

Shi JJ, Xing H, Wang YX, Zhang X, Zhan QM, Geng MY, Ding J, Meng LH.

Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30341-6. doi: 10.1016/j.canlet.2019.05.040. [Epub ahead of print]

PMID:
31173854
14.

Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.

Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, Huang B, Li L, Tang J, Ju J, Guan H, Song B.

Cancer Lett. 2019 Jun 5;459:122-134. doi: 10.1016/j.canlet.2019.05.035. [Epub ahead of print]

PMID:
31173853
15.

Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response.

Huang J, Li J, Li Y, Lu Z, Che Y, Mao S, Lei Y, Zang R, Zheng S, Liu C, Wang X, Li N, Sun N, He J.

Cancer Lett. 2019 Jun 5;459:86-99. doi: 10.1016/j.canlet.2019.05.038. [Epub ahead of print]

PMID:
31173852
16.

p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.

Zhang B, Wang X, Deng J, Zheng H, Liu W, Chen S, Tian J, Wang F.

Cancer Lett. 2019 Jun 1;459:50-58. doi: 10.1016/j.canlet.2019.05.042. [Epub ahead of print]

PMID:
31163195
17.

Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls.

Zhang M, Jabbari N, Satpathy M, Matyunina LV, Wang Y, DeEtte McDonald L, McDonald JF.

Cancer Lett. 2019 Jun 1. pii: S0304-3835(19)30340-4. doi: 10.1016/j.canlet.2019.05.039. [Epub ahead of print]

18.

MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses.

Zhao Q, Yu X, Li M, Liu Y, Han Y, Zhang X, Li XM, Wu X, Qin J, Fang J, Zhang H.

Cancer Lett. 2019 May 31;459:100-111. doi: 10.1016/j.canlet.2019.05.034. [Epub ahead of print]

PMID:
31158430
19.

Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer.

Awasthi N, Kronenberger D, Stefaniak A, Hassan MS, von Holzen U, Schwarz MA, Schwarz RE.

Cancer Lett. 2019 May 30;459:41-49. doi: 10.1016/j.canlet.2019.05.037. [Epub ahead of print]

PMID:
31153980
20.

Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.

Kreuzinger C, von der Decken I, Wolf A, Gamperl M, Koller J, Karacs J, Pfaffinger S, Bartl T, Reinthaller A, Grimm C, Singer CF, Braicu EI, Cunnea P, Gourley C, Smeets D, Boeckx B, Lambrechts D, Perco P, Horvat R, Berns EMJJ, Cacsire Castillo-Tong D.

Cancer Lett. 2019 May 28;459:1-12. doi: 10.1016/j.canlet.2019.05.032. [Epub ahead of print]

PMID:
31150822

Supplemental Content

Loading ...
Support Center